FDA Orange Book

Is there a generic for Lynkuet?

Lynkuet contains elinzanetant. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Lynkuet (elinzanetant). The Orange Book shows its last listed patent expires May 14, 2045 and its last listed exclusivity ends October 24, 2030.

Run it in Rivvi

Map Lynkuet and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Lynkuet products in the Orange Book

Lynkuet products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oral60MGMarketed (Rx)None0None

NDA 219469, held by BAYER HEALTHCARE PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Lynkuet patents

Patents listed for Lynkuet
PatentExpiresCoversUse codeNDA
7683056September 15, 2027Drug substance, Drug productNone219469
10195205May 18, 2036Method of useU-3622219469
12264164March 13, 2039Method of useU-3622219469
11787820March 13, 2039Method of useU-3622219469
10774091March 13, 2039Drug productNone219469
12533358May 14, 2045Method of useU-4402219469

Lynkuet exclusivity

Exclusivity listed for Lynkuet
CodeMeaningExpiresNDA
NCENew chemical entityOctober 24, 2030219469

Lynkuet NDC codes

Questions

Is there a generic for Lynkuet?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Lynkuet (elinzanetant). The Orange Book shows its last listed patent expires May 14, 2045 and its last listed exclusivity ends October 24, 2030.

What is the generic name for Lynkuet?

The active ingredient in Lynkuet is elinzanetant, per the FDA Orange Book.

When does the Lynkuet patent expire?

The last patent listed for Lynkuet in the Orange Book expires May 14, 2045. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Lynkuet and Elinzanetant

Try it on your own data today.

Free to start. Most teams are using it the same day.